A retrospective analysis of EGFR-TKIs and radiotherapy for advanced non-small cell lung cancer patients with EGFR mutations showed that the incidence of RP above grade 3 or even fatal RP was as high as 10% [42]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.